Immunotherapy in new pre-clinical models of HPV-associated oral cancers

References

• Syrjänen S. Human papillomavirus (HPV) in head and neck cancer. J Clin Virol 2005; 32:Suppl 1 S59 - 66; http://dx.doi.org/10.1016/j.jcv.2004.11.017; PMID: 15753013
   PubMed Web of Science ®Google Scholar
• Fakhry C, Gillison ML. Clinical implications of human papillomavirus in head and neck cancers. J Clin Oncol 2006; 24:2606 - 11; http://dx.doi.org/10.1200/JCO.2006.06.1291; PMID: 16763272
   PubMed Web of Science ®Google Scholar
• American Cancer Society. Cancer Facts and Figures 2012. Atlanta, GA - USA: American Cancer Society, 2012. http://www.cancer.org/Research/CancerFactsFigures/ACSPC-031941.
   Google Scholar
• Marur S, D’Souza G, Westra WH, Forastiere AA. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 2010; 11:781 - 9; http://dx.doi.org/10.1016/S1470-2045(10)70017-6; PMID: 20451455
   PubMed Web of Science ®Google Scholar
• Näsman A, Attner P, Hammarstedt L, Du J, Eriksson M, Giraud G, et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?. Int J Cancer 2009; 125:362 - 6; http://dx.doi.org/10.1002/ijc.24339; PMID: 19330833
   PubMed Web of Science ®Google Scholar
• Venuti A, Badaracco G, Rizzo C, Mafera B, Rahimi S, Vigili M. Presence of HPV in head and neck tumours: high prevalence in tonsillar localization. J Exp Clin Cancer Res 2004; 23:561 - 6; PMID: 15743024
   PubMed Web of Science ®Google Scholar
• Wiest T, Schwarz E, Enders C, Flechtenmacher C, Bosch FX. Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene 2002; 21:1510 - 7; http://dx.doi.org/10.1038/sj.onc.1205214; PMID: 11896579
   PubMed Web of Science ®Google Scholar
• Flohr JK, Lee JH. Identical but different: mechanism of cancer development and response to treatment for human papillomavirus-related and non-related squamous cell cancer of the head and neck. S D Med 2008; 61:453 - 45, 455; PMID: 19266896
   PubMedGoogle Scholar
• Badaracco G, Rizzo C, Mafera B, Pichi B, Giannarelli D, Rahimi S, et al. Molecular analyses and prognostic relevance of HPV in head and neck tumors. Oncol Rep 2007; 7:931 - 9
   Google Scholar
• Nygård M, Aagnes B, Bray F, Møller B, Mork J. Population-based evidence of increased survival in human papillomavirus-related head and neck cancer. Eur J Cancer 2012; 48:1341 - 6; http://dx.doi.org/10.1016/j.ejca.2012.03.014; PMID: 22516210
   PubMed Web of Science ®Google Scholar
• Venuti A. Progress and challenges in the vaccine-based treatment of head and neck cancers. J Exp Clin Cancer Res 2009; 28:69; http://dx.doi.org/10.1186/1756-9966-28-69; PMID: 19473517
   PubMed Web of Science ®Google Scholar
• Badaracco G, Venuti A. Human papillomavirus therapeutic vaccines in head and neck tumors. Expert Rev Anticancer Ther 2007; 7:753 - 66; http://dx.doi.org/10.1586/14737140.7.5.753; PMID: 17492938
   PubMed Web of Science ®Google Scholar
• Su JH, Wu A, Scotney E, Ma B, Monie A, Hung C-F, et al. Immunotherapy for cervical cancer: Research status and clinical potential. BioDrugs 2010; 24:109 - 29; http://dx.doi.org/10.2165/11532810-000000000-00000; PMID: 20199126
   PubMed Web of Science ®Google Scholar
• Giorgi C, Franconi R, Rybicki EP. Human papillomavirus vaccines in plants. Expert Rev Vaccines 2010; 9:913 - 24; http://dx.doi.org/10.1586/erv.10.84; PMID: 20673013
   PubMed Web of Science ®Google Scholar
• Massa S, Franconi R, Brandi R, Muller A, Mett V, Yusibov V, et al. Anti-cancer activity of plant-produced HPV16 E7 vaccine. Vaccine 2007; 25:3018 - 21; http://dx.doi.org/10.1016/j.vaccine.2007.01.018; PMID: 17280752
   PubMed Web of Science ®Google Scholar
• Venuti A, Massa S, Mett V, Vedova LD, Paolini F, Franconi R, et al. An E7-based therapeutic vaccine protects mice against HPV16 associated cancer. Vaccine 2009; 27:3395 - 7; http://dx.doi.org/10.1016/j.vaccine.2009.01.068; PMID: 19200826
   PubMed Web of Science ®Google Scholar
• Massa S, Simeone P, Muller A, Benvenuto E, Venuti A, Franconi R. Antitumor activity of DNA vaccines based on the human papillomavirus-16 E7 protein genetically fused to a plant virus coat protein. Hum Gene Ther 2008; 19:354 - 64; http://dx.doi.org/10.1089/hum.2007.122; PMID: 18439124
   PubMed Web of Science ®Google Scholar
• Massa S, Paolini F, Spanò L, Franconi R, Venuti A. Mutants of plant genes for developing cancer vaccines. Hum Vaccin 2011; 7:Suppl 147 - 55; http://dx.doi.org/10.4161/hv.7.0.14577; PMID: 21266841
   PubMed Web of Science ®Google Scholar
• Feltkamp MC, Smits HL, Vierboom MP, Minnaar RP, de Jongh BM, Drijfhout JW, et al. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur J Immunol 1993; 23:2242 - 9; http://dx.doi.org/10.1002/eji.1830230929; PMID: 7690326
   PubMed Web of Science ®Google Scholar
• Lin KY, Guarnieri FG, Staveley-O’Carroll KF, Levitsky HI, August JT, Pardoll DM, et al. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res 1996; 56:21 - 6; PMID: 8548765
   PubMed Web of Science ®Google Scholar
• Ji H, Chang EY, Lin KY, Kurman RJ, Pardoll DM, Wu TC. Antigen-specific immunotherapy for murine lung metastatic tumors expressing human papillomavirus type 16 E7 oncoprotein. Int J Cancer 1998; 78:41 - 5; http://dx.doi.org/10.1002/(SICI)1097-0215(19980925)78:1<41::AID-IJC8>3.0.CO;2-X; PMID: 9724092
   PubMed Web of Science ®Google Scholar
• Decrausaz L, Gonçalves AR, Domingos-Pereira S, Pythoud C, Stehle JC, Schiller J, et al. A novel mucosal orthotopic murine model of human papillomavirus-associated genital cancers. Int J Cancer 2011; 128:2105 - 13; http://dx.doi.org/10.1002/ijc.25561; PMID: 20635385
   PubMed Web of Science ®Google Scholar
• Lou E, Kellman RM, Hutchison R, Shillitoe EJ. Clinical and pathological features of the murine AT-84 orthotopic model of oral cancer. Oral Dis 2003; 9:305 - 12; http://dx.doi.org/10.1034/j.1601-0825.2003.00968.x; PMID: 14629332
   PubMed Web of Science ®Google Scholar
• Schultz-Hector S, Haghayegh S. Beta-fibroblast growth factor expression in human and murine squamous cell carcinomas and its relationship to regional endothelial cell proliferation. Cancer Res 1993; 53:1444 - 9; PMID: 7680286
   PubMed Web of Science ®Google Scholar
• Dinesman A, Haughey B, Gates GA, Aufdemorte T, Von Hoff DD. Development of a new in vivo model for head and neck cancer. Otolaryngol Head Neck Surg 1990; 103:766 - 74; PMID: 2126099
   PubMed Web of Science ®Google Scholar
• Lorenzon L, Mazzetta F, Venuti A, Frega A, Torrisi MR, French D. In vivo HPV 16 E5 mRNA: expression pattern in patients with squamous intra-epithelial lesions of the cervix. J Clin Virol 2011; 52:79 - 83; http://dx.doi.org/10.1016/j.jcv.2011.06.007; PMID: 21767984
   PubMed Web of Science ®Google Scholar
• Syrjänen K, Syrjänen S, Lamberg M, Pyrhönen S, Nuutinen J. Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. Int J Oral Surg 1983; 12:418 - 24; http://dx.doi.org/10.1016/S0300-9785(83)80033-7; PMID: 6325356
   PubMedGoogle Scholar
• Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363:24 - 35; http://dx.doi.org/10.1056/NEJMoa0912217; PMID: 20530316
   PubMed Web of Science ®Google Scholar
• Mognetti B, Di Carlo F, Berta GN. Animal models in oral cancer research. Oral Oncol 2006; 42:448 - 60; http://dx.doi.org/10.1016/j.oraloncology.2005.07.014; PMID: 16266822
   PubMed Web of Science ®Google Scholar
• Hotz HG, Hines OJ, Foitzik T, Reber HA. Animal models of exocrine pancreatic cancer. Int J Colorectal Dis 2000; 15:136 - 43; http://dx.doi.org/10.1007/s003840000229; PMID: 10954185
   PubMed Web of Science ®Google Scholar
• Stakleff KD, Von Gruenigen VE. Rodent models for ovarian cancer research. Int J Gynecol Cancer 2003; 13:405 - 12; http://dx.doi.org/10.1046/j.1525-1438.2003.13317.x; PMID: 12911715
   PubMed Web of Science ®Google Scholar
• Marx J. Medicine. Building better mouse models for studying cancer. Science 2003; 299:1972 - 5; http://dx.doi.org/10.1126/science.299.5615.1972; PMID: 12663895
   PubMed Web of Science ®Google Scholar
• Kwak I, Tsai SY, DeMayo FJ. Genetically engineered mouse models for lung cancer. Annu Rev Physiol 2004; 66:647 - 63; http://dx.doi.org/10.1146/annurev.physiol.66.032102.134301; PMID: 14977417
   PubMed Web of Science ®Google Scholar
• Cui N, Nomura T, Noma H, Yokoo K, Takagi R, Hashimoto S, et al. Effect of YM529 on a model of mandibular invasion by oral squamous cell carcinoma in mice. Clin Cancer Res 2005; 11:2713 - 9; http://dx.doi.org/10.1158/1078-0432.CCR-04-1767; PMID: 15814653
   PubMed Web of Science ®Google Scholar
• Schantz SP, Shillitoe EJ, Brown B, Campbell B. Natural killer cell activity and head and neck cancer: a clinical assessment. J Natl Cancer Inst 1986; 77:869 - 75; PMID: 3020297
   PubMed Web of Science ®Google Scholar
• Woodland DL. Jump-starting the immune system: prime-boosting comes of age. Trends Immunol 2004; 25:98 - 104; http://dx.doi.org/10.1016/j.it.2003.11.009; PMID: 15102369
   PubMed Web of Science ®Google Scholar
• Trimble CL, Peng S, Kos F, Gravitt P, Viscidi R, Sugar E, et al. A phase I trial of a human papillomavirus DNA vaccine for HPV16+ cervical intraepithelial neoplasia 2/3. Clin Cancer Res 2009; 15:361 - 7; http://dx.doi.org/10.1158/1078-0432.CCR-08-1725; PMID: 19118066
   PubMed Web of Science ®Google Scholar
• Hier MP, Black MJ, Shenouda G, Sadeghi N, Karp SE. A murine model for the immunotherapy of head and neck squamous cell carcinoma. Laryngoscope 1995; 105:1077 - 80; http://dx.doi.org/10.1288/00005537-199510000-00013; PMID: 7564839
   PubMed Web of Science ®Google Scholar
• Brasier AR, Tate JE, Habener JF. Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines. Biotechniques 1989; 7:1116 - 22; PMID: 2698191
   PubMed Web of Science ®Google Scholar
• Cattani P, Siddu A, D’Onghia S, Marchetti S, Santangelo R, Vellone VG, et al. RNA (E6 and E7) assays versus DNA (E6 and E7) assays for risk evaluation for women infected with human papillomavirus. J Clin Microbiol 2009; 47:2136 - 41; http://dx.doi.org/10.1128/JCM.01733-08; PMID: 19403762
   PubMed Web of Science ®Google Scholar